MedTrace Logo

Treatments of the Necrosed Immature Teeth (REV)

NCT02064517 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-02-06

No results posted yet for this study

Summary

Estimate if the technique of revascularisation pulpaire (with some hydroxide of calcium) allows to obtain a better forecast of preservation of the tooth without complication than the conventional technique with the creation of an apicale barrier in the MTA in 24 months.

Conditions

  • Clinical and Radiographic Success in 24 Months

Interventions

DEVICE

MTA

Creation of a barrier apicale in the MTA

DEVICE

Hydroxide of calcium

Revascularisation pulpaire with some hydroxide of calcium

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-06-06
Completion
2020-06-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02064517 on ClinicalTrials.gov